9 results about "Human medicine" patented technology

A tool kit for minimally invasive implantation of a tendon fixation implant in the field of arthroscopic human medicine is provided. The tendon fixation implant includes a medial anchor, a lateral anchor, and a base plate. The tool kit includes a medial anchor inserter having a medial anchor drive mandrel and a medial anchor release tube. The medial anchor release tube is designed to receive the medial anchor drive mandrel. The medial anchor drive mandrel is designed both to receive a medial anchor and to introduce the medial anchor into bone by driving it into the latter. The medial anchor drive mandrel has a locking head for locking the medial anchor drive mandrel to the medial anchor release tube. The tool kit includes a base-plate inserter having a handpiece and a base-plate inserter tube designed to receive the base plate of the tendon fixation plate.

The present invention provides novel ionizable lipids and novel lipid nanoparticles comprising messenger RNA (mRNA) useful for the delivery of nucleic acids as defined herein, related pharmaceutical compositions or vaccines for use in human medicine or veterinary medicine, in particular for the treatment and / or prevention of cancer diseases.

The present invention relates to novel compounds and their use as therapeutic agents in human medicine and veterinary medicine. The compounds of the present invention are useful in the treatment and prevention of hyperproliferative disorders, including cancer.

The invention discloses a culture solution for improving the development rate of in-vitro cultured pig blastocysts as well as application and a use method of the culture solution, and belongs to the technical field of livestock embryo engineering. The invention discloses a culture solution for improving the development rate of in-vitro cultured pig blastocysts, which is characterized in that a PZM3 culture solution is used as a basic culture solution, and 5-25ng / mL of tumor necrosis factor superfamily cell factor TNFSF12 is added. According to the present invention, the pig embryo needs to be subjected to in-vitro culture for 4 days in the TNFSF12-free basic culture solution, and then is transferred to the TNFSF12-containing basic culture solution so as to be continuously cultured for 2 days, such that the generation efficiency of the pig blastocyst can be effectively improved, and the support is provided for the application of the pig in-vitro fertilization, the somatic cell nuclear transfer, the embryo genome selection and other embryo engineering technologies in the agricultural breeding and the human medicine;

The present application provides a kind of detection method of bacterial endotoxin in PHA gel filling agent.The filling agent of the present application comprises PHA microspheres, gel carrier sodium carboxymethyl cellulose, osmotic pressure regulator, pH regulator and water for injection, the present application systematically studies the influence of gel carrier and osmotic pressure regulator on the performance of composition shear viscosity and osmotic pressure, and scientifically selects the excellent and stable gel prescription.The present application accidentally finds that the combination of water and a small amount of dichloromethane can realize the sufficient release of endotoxin, and accurately detect its content.The method of the present application can effectively ensure the safety of human medicine, and has important industrial value.

A kit for minimally invasive implantation of a tendon fixation implant in the field of arthroscopic human medicine, wherein the tendon fixation implant comprises a medial anchor (13), a lateral anchor (23) and a base plate (51), wherein the kit comprises a medial anchor inserter (10), wherein the medial anchor inserter (10) comprises a medial anchor drive spindle (11) and a medial anchor release tube (12), wherein the medial anchor release tube (12) is designed to receive the medial anchor drive spindle (11), wherein the medial anchor drive spindle (11) is designed to receive a medial anchor (13) and to introduce the medial anchor (13) into a bone, wherein the medial anchor drive spindle (11) has a locking head (16) for locking the medial anchor drive spindle (11) on the medial anchor release tube (12).

To provide new short chain oligopeptides, the use of such peptides in human medicine, and pharmaceutical compositions comprising them. Specifically, the invention provides for the use of these peptides and compositions in the treatment of, for example, inflammation.SOLUTION: Disclosed are peptide compounds having a specific amino acid sequence, and positional isomers, stereoisomers, and pharmaceutically or cosmetically acceptable salts of the peptide compounds. These compounds are particularly useful in the treatment of conditions characterized by inflammation, including wounds, burns, and disorders of the mucous membranes, such as anorectal disease, inflammatory bowel disease, gynecological disease, and dental disease.SELECTED DRAWING: Figure 1

A tool kit for minimally invasive implantation of a tendon fixation implant in the field of arthroscopic human medicine is provided. The tendon fixation implant includes a medial anchor, a lateral anchor, and a base plate. The tool kit includes a medial anchor inserter having a medial anchor drive mandrel and a medial anchor release tube. The medial anchor release tube is designed to receive the medial anchor drive mandrel. The medial anchor drive mandrel is designed both to receive a medial anchor and to introduce the medial anchor into bone by driving it into the latter. The medial anchor drive mandrel has a locking head for locking the medial anchor drive mandrel to the medial anchor release tube. The tool kit includes a base-plate inserter having a handpiece and a base-plate inserter tube designed to receive the base plate of the tendon fixation plate.

The present invention refers to novel compounds and their use as therapeutic agents in human medicine. The compounds of the present invention can be used in the treatment and / or prevention of a disease caused by and / or associated with insufficient TLX activity. Further, the present invention refers to a method of comprising administering an effective amount of the novel compounds.